CBD of Denver Wants to Provide an Update on Progress with the Company and Additional Corporate Updates
Denver, Colorado--(Newsfile Corp. - August 7, 2023) - CBD of Denver (OTC Pink: CBDD) would like to update its shareholders...
News
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
Model N Earns Recognition for Company Culture, Named by Fortune as a Best Place to Work for Millennial Employees
Revenue optimization and compliance leader included in Fortune’s 2023 Best Workplaces for Millennials listSAN MATEO, Calif.--(BUSINESS WIRE)--Fortune Media and Great...
Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
Masimo PSi, a Processed EEG Parameter, “Better Captured” Changes in Brain State Compared to Other Assessment MethodsIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ:...
Accuhealth Introduces First Cellular-Enabled Peak Flow Meter
Device Will Be Critical in Aiding Patients Suffering From COPDMCALLEN, TX / ACCESSWIRE / August 7, 2023 / Accuhealth, a...
Stemtech Showcases Remarkable Strides in Business Development and Revenue Growth
Achieves 20% Revenue Surge in Key Markets, Demonstrating Success of Strategic Initiatives and Growing Market DemandMIRAMAR, FL / ACCESSWIRE /...
Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health’s Crofelemer for Neratinib-induced Diarrhea
A significant proportion of patients undergoing cancer therapy experience diarrhea, which has the potential to cause dehydration and non-adherence to...
BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Ahti Paananen
BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST) BBS-Bioactive Bone Substitutes Oyj - Managers'...
BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Jarmo Halonen
BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST) BBS-Bioactive Bone Substitutes Oyj - Managers'...
BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Pekka Jalovaara
BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST) BBS-Bioactive Bone Substitutes Oyj - Managers'...
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
PALO ALTO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
GT Biopharma Reports Second Quarter 2023 Financial Results
Cash of approximately $18.0 million as of June 30, 2023, provides ample runway to fund operations into Q3 2024; anticipated...
Smart for Life Recaps Significant Events Year-to-Date
Review Includes Interactive Links to Company’s Major AnnouncementsMIAMI, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL)...
GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Models
Data presented at The Autoimmunity Conference hosted by the Federation of American Societies for Experimental Biology (FASEB) GRI-0803 in development...
Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting
Real-world study that explored the healthcare utilization resource utilization among patients receiving GIMOTI with and without prior treatment with oral...
IO Biotech, Inc. Announces $75 Million Private Placement Financing
Offering includes participation from both new and existing healthcare-dedicated investorsProceeds extend the company’s cash runway into the fourth quarter of...
Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms
New migraine data builds on prior clinical studies in depression Migraine trial results Migraine trial results Depression trial results Depression...
Preclinical Data Showing Strong Immunogenicity and Protection with IMUNON’s PlaCCine DNA-Based Vaccines Modality Available Online on bioRxiv
LAWRENCEVILLE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral...
ABVC Corporate Update and CEO’s Letter to Shareholders
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company...